Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $36.65 Analyst target: $57.86 Upside: 57.87%
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
See the full interactive analysis & chart →Informational only — not investment advice.